Your AI-Trained Oncology Knowledge Connection!
Allison Winter, MD, is a member of the Department of Hematology and Medical Oncology at the Cleveland Clinic in Ohio.
Dr Winter on the Role of Treatment History in Richter Transformation
Allison Winter, MD, emphasizes the importance of carefully evaluating treatment history in patients with Richter transformation from CLL.
Read More
Dr Winter on Unmet Needs in Richter Transformation for Patients With CLL
Allison Winter, MD, discusses unmet needs for patients with Richter transformation from CLL.
Dr Winter on Real-World Outcomes With Liso-Cel in Richter Transformation
Allison Winter, MD, discusses data from a retrospective analysis evaluating real-world outcomes with liso-cel in patients with Richter transformation.
Dr. Winter on Emerging Agents in CLL
Allison Winter, MD, discusses emerging agents in chronic lymphocytic leukemia.
Dr. Winter on the Role of Frontline Targeted Therapies in CLL
Allison Winter, MD, hematologist/medical oncologist, Cleveland Clinic, discusses the role of frontline targeted therapies in chronic lymphocytic leukemia.
Dr. Winter on the Utility of PI3K Inhibitors in CLL
Allison Winter, MD, discusses the utility of PI3K inhibitors in chronic lymphocytic leukemia.
Pirtobrutinib Improves Patient-Reported Outcomes in Relapsed/Refractory CLL/SLL
MAIC Analysis Shows PFS Favorability With Zanubrutinib vs Acalabrutinib/Venetoclax in CLL
Isa-KRd Yields Prolonged MRD Negativity vs KRd in Newly Diagnosed Myeloma
Elranatamab Triplet Yields Nearly 100% ORR in Newly Diagnosed Multiple Myeloma